Biography and Research Information
OverviewAI-generated summary
Z. Chauhan's research focuses on clinical studies related to patient recovery and treatment efficacy. Recent publications include work on the potential use of chlorpheniramine intranasal spray for accelerating COVID-19 recovery in an outpatient setting, as part of the Accros III trial. Additionally, Chauhan has contributed to discussions on glycemic thresholds for cataract surgery, publishing a reply to a comment on this topic. Chauhan's work involves analyzing clinical data to understand treatment outcomes and patient responses in various medical contexts. The researcher's publication record includes 8 total publications with 49 citations and an h-index of 2, indicating recent and ongoing activity in the field.
Metrics
- h-index: 2
- Publications: 8
- Citations: 50
Selected Publications
-
Reply to Comment on: “Is There a Safe Glycemic Threshold for Cataract Surgery?” (2025)
Collaboration Network
Top Collaborators
- Chlorpheniramine Intranasal Spray (0.4%) to Accelerate COVID-19 Clinical Recovery in an Outpatient Setting: Accros III
- Chlorpheniramine Intranasal Spray (0.4%) to Accelerate COVID-19 Clinical Recovery in an Outpatient Setting: Accros III
- Chlorpheniramine Intranasal Spray (0.4%) to Accelerate COVID-19 Clinical Recovery in an Outpatient Setting: Accros III
- Chlorpheniramine Intranasal Spray (0.4%) to Accelerate COVID-19 Clinical Recovery in an Outpatient Setting: Accros III
- Chlorpheniramine Intranasal Spray (0.4%) to Accelerate COVID-19 Clinical Recovery in an Outpatient Setting: Accros III
- Chlorpheniramine Intranasal Spray (0.4%) to Accelerate COVID-19 Clinical Recovery in an Outpatient Setting: Accros III
- Chlorpheniramine Intranasal Spray (0.4%) to Accelerate COVID-19 Clinical Recovery in an Outpatient Setting: Accros III
- Chlorpheniramine Intranasal Spray (0.4%) to Accelerate COVID-19 Clinical Recovery in an Outpatient Setting: Accros III
- Chlorpheniramine Intranasal Spray (0.4%) to Accelerate COVID-19 Clinical Recovery in an Outpatient Setting: Accros III
- Chlorpheniramine Intranasal Spray (0.4%) to Accelerate COVID-19 Clinical Recovery in an Outpatient Setting: Accros III
- Reply to Comment on: “Is There a Safe Glycemic Threshold for Cataract Surgery?”
- Reply to Comment on: “Is There a Safe Glycemic Threshold for Cataract Surgery?”
Similar Researchers
Based on overlapping research topics